Quick Answer
Cue Biopharma, Inc. reported Research And Development Expense of $37.74 million for the year ending 2025.
- Cue Biopharma, Inc. showed an increase of +4.0% in Research And Development Expense from 2024 to 2025.
- This data is from Cue Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Cue Biopharma, Inc.'s Research And Development Expense has grown by 99.7%.
- Historical annual values: Fiscal year 2025: $37.74 million | Fiscal year 2024: $36.30 million | Fiscal year 2023: $40.80 million | Fiscal year 2022: $38.58 million | Fiscal year 2021: $41.35 million | Fiscal year 2020: $33.55 million | Fiscal year 2019: $27.49 million | Fiscal year 2018: $28.54 million | Fiscal year 2017: $18.90 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: